Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 209-214

  Van Duinen, N ^a   Steenvoorden, D ^a   Kema, I P ^b   Jansen, J C ^a   Vriends, A H J T ^a   Bayley, J P ^a   Smit, J W A ^a   Romijn, J A ^a   Corssmit, E P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3 O METHYLDOPAMINE; CATECHOLAMINE; DOPAMINE; MANDELIC ACID; NORADRENALIN; NORMETADRENALIN;

ADULT; ARTICLE; CATECHOLAMINE EXCRETION; CONTROLLED STUDY; DIAPHORESIS; DOPAMINE URINE LEVEL; FEMALE; GENOTYPE; HEAD AND NECK CARCINOMA; HEAD AND NECK PARAGANGLIOMA; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PREVALENCE; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 75149142161     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1632     Document Type: Article

References (19)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C 2004 Pathology and genetics: WHOclassification of tumours of endocrine organs. Oxford, UK: Oxford University Press
2. Pacak K, Keiser H, Eisenhofer G 2005 Pheochromocytoma. In: Textbook of endocrinology. 5th ed. Philadelphia: Elsevier Saunders, Inc.; 2501-2534
3. Zak FG, Lawson W 1982 The paraganglionic chemoreceptor system. 1st ed. New York: Springer-Verlag New York Inc.
4. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young Jr WF 2001 Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210-5216
5. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW, Pacak K 2007 Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92:779-786
6. Jeffery J, Devendra D, Farrugia J, Gardner D, Murphy MJ, Williams R, Ayling RM, Wilkin TJ 2006 Increased urinary dopamine excretion in association with bilateral carotid body tumours-clinical, biochemical and genetic findings. Ann Clin Biochem 43:156-160
7. Koch CA, Rodbard JS, Brouwers FM, Eisenhofer G, Pacak K 2003 Hypotension in a woman with a metastatic dopamine-secreting carotid body tumor. Endocr Pract 9:310-314
8. Mínguez-Castellanos A, Escamilla-Sevilla F, Hotton GR, Toledo-Aral JJ, Ortega-Moreno A, Méndez-Ferrer S, Martín-Linares JM, Katati MJ, Mir P, Villadiego J, Meersmans M, Pérez-García M, Brooks DJ, Arjona V, López-Barneo J 2007 Carotid body auto-transplantation in Parkinson disease: a clinical and positron emission tomography study. J Neurol Neurosurg Psychiatry 78:825-831
9. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K 2005 Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068-2075
10. John H, Ziegler WH, Hauri D, Jaeger P 1999 Pheochromocytomas: can malignant potential be predicted? Urology 53:679-683
11. Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P 1986 Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154-1162
12. Kema IP, Meiborg G, Nagel GT, Stob GJ, Muskiet FA 1993 Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. J Chromatogr 617:181-189
13. Willemsen JJ, Ross HA, Wolthers BG, Sweep CG, Kema IP 2001 Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Ann Clin Biochem 38:722-730
14. Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE 2006 Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet 7:1
15. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Bröcker-Vriends AH, van Der Mey AG, van Ommen GJ, Cornelisse CJ, Devilee P 2001 Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31:274-281
16. Jansen JC, van den Berg R, Kuiper A, van derMey AG, Zwinderman AH, Cornelisse CJ 2000 Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 88:2811-2816
17. Bradshaw JW, Jansen JC 2005 Management of vagal paraganglioma: is operative resection really the best option? Surgery 137: 225-228
18. Dubois LA, Gray DK 2005 Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg 29:909-913
19. Januszewicz W, Wocial B, Januszewicz A, Gryglas P, Prejbisz A 2001 Dopamine and dopa urinary excretion in patients with pheochromocytoma- diagnostic implications. Blood Press 10:212-216